Apr 17, 2026, 08:01 by

Takara Bio and Resistomap Oy today announce a strategic agreement to deepen their partnership in developing streamlined end-to-end solutions for high throughput antimicrobial resistance surveillance from environmental samples.

Apr 16, 2026, 11:27 by

Apr 16, 2026, 11:27 by

Apr 16, 2026, 11:27 by

The Board of Directors of Medix Biochemica appoints Petra Furu as Chief Executive Officer of the company, effective 1 June 2026.

Apr 16, 2026, 01:23 by User Not Found

Clinical Research News | Following an eye-opening experience at China’s largest biotechnology and life sciences event, Veristat is positioning itself as a first mover in accommodating the regulatory needs of multiple Chinese companies eager to enter European and North American markets. The shift comes in response to government policy reforms over the past decade, with purpose-built R&D cities and science parks in more recent years acting as physical accelerators.

Apr 15, 2026, 08:33 by

Biognosys Group today announced a major collaboration with The Michael J. Fox Foundation for Parkinson’s Research to advance the development of highly sensitive and quantitative biomarker assays for Parkinson’s disease.

Apr 15, 2026, 08:33 by

Enhanced Compliance Inc. today announced the appointment of Khalid Raja (Raj) as Senior Vice President, Strategic Growth & Advisory, effective April 13, 2026.

Apr 14, 2026, 01:00 by User Not Found

Clinical Research News | Earlier this year, the U.S. Food and Drug Administration (FDA) made a single pivotal clinical trial the default requirement for getting a medicine to market in lieu of the traditional two-trial mandate. It was a controversial move designed to reduce clinical development costs for drug sponsors, but it comes with the peril of potential project failure if study results aren’t rigorously defensible—or if companies fail to invest heavily in the quality of that single trial using readily accessible tools for data monitoring, artificial intelligence (AI), and biosimulation.

Apr 10, 2026, 10:59 by

Dr. Al Mutar brings deep expertise in gastrointestinal oncology and early-phase clinical trials and will help to expand access to innovative therapies across North Texas.

Apr 10, 2026, 10:59 by

Review highlights multi-pathway, mechanistically informed approaches to obesity treatment

Apr 10, 2026, 10:59 by

Apr 9, 2026, 08:04 by

Certara Appoints Dr. Britta Wagenhuber as Head of Quantitative Systems Pharmacology (QSP) Consultancy

Apr 9, 2026, 01:01 by User Not Found

Clinical Research News | Clinical research is entering a phase where “using AI” is no longer the headline, and redesigning clinical operations becomes the real work. Mike Sullivan, head of IT globally for development operations at Bristol Myers Squibb, joins The Scope of Things to discuss a persistent industry problem: clinical insight latency, the long delay between data being generated at sites and meaningful decisions being made by sponsors.

Apr 8, 2026, 01:01 by User Not Found

Clinical Research News | At Cleveland Clinic, a “medically trained” AI system is patient-finding for clinical trials, eliminating the tedium of manual chart reviews for sponsors and investigators requesting digital assistance. Synapsis AI, a Dyania Health technology, was vetted for the job and initially deployed at Cleveland Clinic’s Taussig Cancer Center and its Heart, Vascular and Thoracic Institute.

Apr 7, 2026, 01:00 by User Not Found

Clinical Research News | Cancer recurrence is a significant health issue and a major concern for survivors but could potentially be transformed into a manageable chronic condition with the advent of a magnetic nanoparticle hyperthermia system developed by the Israeli startup New Phase and newly installed at the Mayo Clinic last December. The novel technology uses iron oxide-containing nanoparticles that amass in tumors, which are then heated by an electromagnetic field to destroy them.

Apr 3, 2026, 08:09 by

Plasmidsaurus has announced two transformative evolutions of its RNA-Seq ecosystem.

Apr 3, 2026, 01:31 by User Not Found

Clinical Research News | Food and Drug Administration Commissioner Marty Makary has been signaling a potential change to how clinical trials are conducted. Since assuming the Commissioner role, he has championed "continuous trials"  to accelerate drug development, calling the current phased approach inefficient.

Apr 1, 2026, 08:18 by

Apr 1, 2026, 08:18 by

LabConnect has launched SampleGISTICS 2.0, a mobile application designed to replace legacy digital pen technology and paper-based requisitions with a smartphone-based workflow. The platform enables clinical research sites to scan and transmit sample data in real time, providing immediate visibility into sample location and stability from the point of collection through laboratory intake. This digitization aims to reduce manual data entry errors and streamline logistics for global decentralized clinical trials.

Mar 31, 2026, 08:16 by